These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28083984)

  • 1. Whole genome sequencing analysis of lung adenocarcinoma in Xuanwei, China.
    Wang X; Li J; Duan Y; Wu H; Xu Q; Zhang Y
    Thorac Cancer; 2017 Mar; 8(2):88-96. PubMed ID: 28083984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Somatic Mutations in Air Pollution-Related Lung Cancer.
    Yu XJ; Yang MJ; Zhou B; Wang GZ; Huang YC; Wu LC; Cheng X; Wen ZS; Huang JY; Zhang YD; Gao XH; Li GF; He SW; Gu ZH; Ma L; Pan CM; Wang P; Chen HB; Hong ZP; Wang XL; Mao WJ; Jin XL; Kang H; Chen ST; Zhu YQ; Gu WY; Liu Z; Dong H; Tian LW; Chen SJ; Cao Y; Wang SY; Zhou GB
    EBioMedicine; 2015 Jun; 2(6):583-90. PubMed ID: 26288819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.
    Bonfiglio S; Vanni I; Rossella V; Truini A; Lazarevic D; Dal Bello MG; Alama A; Mora M; Rijavec E; Genova C; Cittaro D; Grossi F; Coco S
    BMC Cancer; 2016 Aug; 16(1):692. PubMed ID: 27578032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular epidemiology study in Xuanwei: the relationship among 
coal type, genotype and lung cancer risk].
    Li J; He J; Tang R; Hu W; Lan Q; He X; Li Y; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2015 Jan; 18(1):16-22. PubMed ID: 25603868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of lung adenocarcinoma in Xuanwei, China.
    Wu H; Meng S; Xu Q; Wang X; Wang J; Gong R; Song Y; Duan Y; Zhang Y
    Eur J Cancer Prev; 2016 Nov; 25(6):508-17. PubMed ID: 26695082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients.
    Renieri A; Mencarelli MA; Cetta F; Baldassarri M; Mari F; Furini S; Piu P; Ariani F; Dragani TA; Frullanti E
    Lung Cancer; 2014 Aug; 85(2):168-74. PubMed ID: 24954872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
    Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
    Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
    Hintzsche J; Kim J; Yadav V; Amato C; Robinson SE; Seelenfreund E; Shellman Y; Wisell J; Applegate A; McCarter M; Box N; Tentler J; De S; Robinson WA; Tan AC
    J Am Med Inform Assoc; 2016 Jul; 23(4):721-30. PubMed ID: 27026619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations.
    Chevrier S; Arnould L; Ghiringhelli F; Coudert B; Fumoleau P; Boidot R
    Int J Oncol; 2014 Sep; 45(3):1167-74. PubMed ID: 24990411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.
    Shen R; Seshan VE
    Nucleic Acids Res; 2016 Sep; 44(16):e131. PubMed ID: 27270079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.
    Shen M; Vermeulen R; Rajaraman P; Menashe I; He X; Chapman RS; Yeager M; Thomas G; Burdett L; Hutchinson A; Yuenger J; Chanock S; Lan Q
    Environ Mol Mutagen; 2009 May; 50(4):285-90. PubMed ID: 19170196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/β-catenin signaling pathway mutations.
    Yuan W; Zhang Z; Dai B; Wei Q; Liu J; Liu Y; Liu Y; He L; Zhou D
    Cancer; 2016 Jun; 122(11):1689-96. PubMed ID: 26998897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genome variations in patients with lung adenocarcinoma using whole genome re‑sequencing.
    Li G; Mei Y; Yang F; Yi S; Wang L
    Mol Med Rep; 2017 Dec; 16(6):9464-9472. PubMed ID: 29039585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.
    Preusser M; Berghoff AS; Koller R; Zielinski CC; Hainfellner JA; Liebmann-Reindl S; Popitsch N; Geier CB; Streubel B; Birner P
    Eur J Cancer; 2015 Sep; 51(13):1803-11. PubMed ID: 26164066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
    Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
    Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole exome sequencing identifies driver mutations in asymptomatic computed tomography-detected lung cancers with normal karyotype.
    Belloni E; Veronesi G; Rotta L; Volorio S; Sardella D; Bernard L; Pece S; Di Fiore PP; Fumagalli C; Barberis M; Spaggiari L; Pelicci PG; Riva L
    Cancer Genet; 2015 Apr; 208(4):152-5. PubMed ID: 25850996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profiling of lung adenocarcinoma in Xuanwei, China: A preliminary study.
    Hu Z; Wang X; Yang Y; Zhao Y; Shen Z; Huang Y
    Medicine (Baltimore); 2019 May; 98(21):e15717. PubMed ID: 31124951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of somatic alterations in stage I lung adenocarcinomas by next-generation sequencing.
    Zhao Y; Yang J; Chen Z; Gao Z; Zhou F; Li X; Li J; Shi S; Feng X; Sun N; Yao R; Zhou C; Chang S; Li M; Zhou Y; Li L; Zhang X; He J
    Genes Chromosomes Cancer; 2014 Apr; 53(4):289-98. PubMed ID: 24449147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitizing effect of shRNA-mediated ERCC1 silencing on a Xuanwei lung adenocarcinoma cell line and its clinical significance.
    Wang W; Zhang L; Liu L; Zheng Y; Zhang Y; Yang S; Shi R; Wang S
    Oncol Rep; 2017 Apr; 37(4):1989-1997. PubMed ID: 28260069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.